FDA approves LLY's Cymbalta

FDA approved Cymbalta duloxetine from Eli Lilly (LLY) to treat major depressive disorder. LLY expects to launch the once-daily oral inhibitor of serotonin (5-HT) and norepinephrine transporters toward...